EXS	ed
PER	Malignancy
NIL	HANNOVER
NIL	,
NIL	GERMANY
AND	–
IST	Breast
CON	cancer
NOW	is
AND	among
DEF	the
TOP	most
EXG	life-threatening
AND	of
CON	malignancies
NIL	,
EXS	affecting
AND	about
QUC	one
REL	in
QUC	ten
CON	women
REL	in
DEF	the
IST	Western
CON	world
NIL	.
EXS	Taking
DEF	the
CON	family
CON	history
AND	of
INT	100
IST	healthy
CON	women
NIL	,
TOP	at
EXS	least
QUC	one
IST	affected
CON	first-degree
AND	relative
POS	can
EXS	be
EXS	found
REL	in
IST	up
REL	to
QUC	15
AND	of
PRO	them
NIL	.
AND	Indeed
NIL	,
CON	investigations
NOW	have
EXT	shown
SUB	that
DEF	the
CON	risk
AND	of
EXG	developing
CON	breast
CON	cancer
NOW	is
INT	roughly
EXS	doubled
REL	in
CON	females
REL	with
DIS	a
CON	family
CON	history
AND	of
CON	breast
CON	cancer
NIL	.
REL	In
YOC	1994
AND	-
YOC	1995
NIL	,
DEF	the
IST	human
CON	genes
NIL	BRCA1
COO	and
UNK	BRCA2
PST	were
EXS	identified
AND	as
IST	major
CON	culprits
NIL	.
CON	Dozens
AND	of
HAS	their
CON	mutations
NOW	are
EXS	associated
REL	with
DIS	an
IST	increased
CON	risk
AND	of
IST	hereditary
CON	breast
AND	and
IST	ovarian
CON	cancer
NIL	.
CON	Women
AND	who
NOW	have
DIS	an
IST	abnormal
CON	BRCA1
DIS	or
IST	BRCA2
CON	gene
EXS	run
DIS	a
IST	lifetime
CON	risk
AND	of
IST	up
REL	to
QUC	85
UOM	%
AND	of
EXG	developing
CON	breast
CON	cancer
NIL	,
SUB	while
DEF	the
IST	increased
CON	risk
AND	of
EXG	developing
IST	ovarian
CON	cancer
NOW	is
INT	about
QUC	55
UOM	%
REL	for
CON	women
REL	with
DEF	BRCA1
CON	mutations
AND	and
INT	about
INT	25
UOM	%
REL	for
CON	women
REL	with
PRX	BRCA2
CON	mutations
NIL	.
TOP	Most
IST	recently
NIL	,
IST	huge
CON	studies
EXS	analyzing
CON	effects
AND	of
IST	single
CON	nucleotide
CON	variations
REL	in
IST	genomic
CON	DNA
NIL	,
IST	so-called
IST	single
CON	nucleotide
CON	polymorphisms
SUB	(
ORG	SNP
NIL	)
NIL	,
REL	on
CON	breast
CON	cancer
CON	risk
AND	of
IST	BRCA1/BRCA2
CON	mutation
CON	carriers
NOW	have
EXS	identified
IST	so-called
CON	modifier
CON	SNP
AND	that
POS	can
EXS	decrease
DIS	or
EXS	increase
DEF	the
IST	individual
CON	lifetime
CON	risk
NIL	.
PRO	We
NOW	have
IST	also
EXS	learned
SUB	that
XCL	only
QUC	20
AND	-
QUC	40
UOM	%
AND	of
DEF	the
CON	breast
CON	cancers
SUB	that
REL	cluster
REL	in
CON	families
EXS	come
REL	from
UNK	BRCA1
DIS	or
UNK	BRCA2
CON	germline
CON	mutations
AND	–
IST	genetic
CON	alterations
AND	that
NOW	are
EXS	present
REL	from
CON	birth
REL	in
AND	every
CON	cell
AND	of
DEF	the
CON	body
AND	and
POS	can
EXS	be
EXS	transmitted
REL	to
DEF	the
CON	offspring
NIL	.
IST	Increased
CON	breast
CON	cancer
CON	risk
NOW	is
ALT	also
EXS	known
SUB	to
EXS	be
EXS	associated
REL	with
QUV	several
EXS	inherited
CON	syndromes
NIL	,
AND	such
AND	as
CON	Li-Fraumeni
NIL	syndrome
NIL	,
DIS	a
CON	condition
AND	that
NOW	is
IST	further
EXS	associated
REL	with
CON	childhood
CON	onset
AND	of
IST	multiple
CON	malignancies
AND	including
IST	soft
CON	tissue
CON	sarcomas
EQU	,
CON	leukemias
NIL	,
AND	and
CON	brain
CON	tumors
NIL	.
REL	In
TOP	most
CON	cases
AND	of
IST	familial
CON	breast
CON	cancer
EQU	,
IST	however
EQU	,
IST	genetic
CON	predisposition
NOW	remains
EXS	elusive
NIL	.
AND	Indeed
NIL	,
NOT	no
IST	further
CON	genes
NOW	have
PFT	been
EXS	found
HAS	whose
CON	mutations
NOW	are
EXS	associated
REL	with
IST	high
CON	lifetime
CON	risks
AND	of
EXG	developing
CON	breast
CON	cancer
NIL	.
AND	Recently
NIL	,
IST	new
CON	approaches
SUB	to
EXS	investigating
CON	genes
EXS	involved
REL	in
CON	DNA
CON	repair
NIL	,
AND	and
IST	huge
CON	studies
AND	of
DEF	the
CON	effect
AND	of
CON	SNP
REL	on
CON	breast
CON	cancer
CON	risk
NIL	,
NOW	have
EXS	identified
QUC	two
CON	classes
AND	of
CON	breast
CON	cancer
CON	susceptibility
CON	factors
NIL	.
QUC	One
CON	class
NOW	contains
CON	mutations
REL	in
CON	genes
EXS	involved
REL	in
CON	DNA
CON	repair
NIL	.
HAS	Their
CON	frequency
NOW	is
INT	rather
EXS	rare
AND	and
IST	certain
CON	mutations
POS	can
EXS	be
EXS	found
XCL	only
REL	in
IST	distinct
CON	populations
NIL	,
BUT	but
PRX	this
CON	class
AND	of
CON	susceptibility
CON	factors
NOW	is
EXS	associated
REL	with
DIS	a
INT	moderately
IST	increased
CON	breast
CON	cancer
CON	risk
NIL	.
AND	Considering
CON	frequency
AND	and
CON	risk
NIL	,
PRX	this
CON	class
AND	of
CON	breast
CON	cancer
CON	susceptibility
CON	factors
POS	can
EXS	be
EXS	called
CON	“rare
EQU	,
CON	intermediate-penetrance
CON	mutations
NIL	”
NIL	.
DEF	The
ALT	other
CON	class
NOW	involves
QUE	what
NOW	are
EXS	known
AND	as
NIL	“
IST	common
NIL	,
CON	low-penetrance
CON	variants
NIL	.
